Skip to Content

Join the 'Nausea / Vomiting - Chemotherapy Induced' group to help and get support from people like you.

Nausea / Vomiting - Chemotherapy Induced News

FDA Approves Intravenous Formulation of Akynzeo (fosnetupitant/palonosetron) for Chemotherapy-Induced Nausea and Vomiting

Posted 7 May 2018 by Drugs.com

Lugano, Switzerland April 20, 2018 – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announces that the U.S. Food and Drug Administration (FDA) has approved the intravenous formulation of Akynzeo (NEPA, a fixed antiemetic combination of fosnetupitant, 235mg, and palonosetron, 0.25mg) as an alternative treatment option for patients experiencing CINV. T ...

FDA Medwatch Alert: Varubi (rolapitant) Injectable Emulsion: Health Care Provider Letter - Anaphylaxis and Other Serious Hypersensitivity Reactions

Posted 17 Jan 2018 by Drugs.com

ISSUE: Anaphylaxis, anaphylactic shock and other serious hypersensitivity reactions have been reported in the postmarketing setting, some requiring hospitalization. These reactions have occurred during or soon after the infusion of Varubi (rolapitant) injectable emulsion. Most reactions have occurred within the first few minutes of administration. Symptoms of anaphylaxis can include wheezing or ...

FDA Approves Cinvanti (aprepitant) Injectable Emulsion for the Prevention of Acute and Delayed Chemotherapy-Induced Nausea and Vomiting (CINV)

Posted 14 Nov 2017 by Drugs.com

SAN DIEGO--(BUSINESS WIRE)--Nov. 9, 2017-- Heron Therapeutics, Inc. (Nasdaq: HRTX) (the Company or Heron), a commercial-stage biotechnology company focused on developing novel, best-in-class treatments to address some of the most important unmet patient needs, today announced that the U.S. Food and Drug Administration (FDA) has approved Cinvanti (aprepitant) injectable emulsion, for intravenous ...

Tesaro Announces U.S. FDA Approval of Varubi IV for Delayed Nausea and Vomiting Associated With Cancer Chemotherapy

Posted 30 Oct 2017 by Drugs.com

WALTHAM, Mass., Oct. 25, 2017 (GLOBE NEWSWIRE) – Tesaro, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Varubi (rolapitant) IV in combination with other antiemetic agents in adults for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer ...

Medical Marijuana Won't Help Most Sick Kids

Posted 23 Oct 2017 by Drugs.com

MONDAY, Oct. 23, 2017 – Medical marijuana appears to hold only limited promise for sick children and teenagers, a new review suggests. It can help kids fighting cancer with chemotherapy-related nausea and vomiting, and it can control seizures somewhat in children with epilepsy, said study author Dr. Shane Shucheng Wong. He is a psychiatrist with Massachusetts General Hospital, in Boston. But ...

9 of 10 Docs Unprepared to Prescribe Marijuana

Posted 19 Sep 2017 by Drugs.com

TUESDAY, Sept. 19, 2017 – Although it's becoming more commonplace, medical marijuana is rarely discussed in U.S. medical schools, a new study shows. "Medical education needs to catch up to marijuana legislation," said senior author Dr. Laura Jean Bierut, a professor of psychiatry at Washington University School of Medicine in St. Louis. "Physicians in training need to know the benefits and ...

Cancer Treatment Can Affect Your Food Preferences

Posted 19 Sep 2017 by Drugs.com

TUESDAY, Sept. 19, 2017 – Cancer therapies often change patients' sense of taste, which may affect what they like to eat, according to a nutrition expert. "Increased taste sensitivities are more common than a muting of taste," said Catherine Carpenter, professor of clinical nutrition at UCLA's David Geffen School of Medicine. "Usually, the type of taste sensitivity encountered is one of a ...

Germs, Mold Found in Some Medical Pot

Posted 15 Feb 2017 by Drugs.com

WEDNESDAY, Feb. 15, 2017 – Medical marijuana carries infectious bacteria and fungi that can pose a life-threatening risk to cancer patients who use pot to help with side effects of chemotherapy, a new study suggests. The study was initially prompted by the death of a man using medical marijuana to combat the side effects of cancer treatment. His death was believed to be caused by a fungus from ...

Is Chemo Overused in Younger Colon Cancer Patients?

Posted 25 Jan 2017 by Drugs.com

WEDNESDAY, Jan. 25, 2017 – Young and middle-aged colon cancer patients may be getting chemotherapy more often than is warranted, a new study suggests. "Most of the young patients received postoperative systemic chemotherapy, including multi-[drug] regimens, which are currently not recommended for most patients with early stage colon cancer," the study authors wrote. The research team was led by ...

Vomiting Disorder on Rise in Weed-Friendly Colorado

Posted 6 Jan 2017 by Drugs.com

THURSDAY, Jan. 5, 2017 – Long-term heavy marijuana use can cause chronic vomiting and abdominal pain in some people, new research suggests. And the syndrome could become more frequent and pervasive as more states legalize use of the drug, according to health experts. Cases of the disorder, which is called cannabinoid hyperemesis syndrome (CHS), doubled in Colorado as access to legal marijuana ...

Heron Therapeutics Announces FDA Approval of Sustol (granisetron) Extended-Release Injection for the Prevention of Chemotherapy-Induced Nausea and Vomiting

Posted 10 Aug 2016 by Drugs.com

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Aug. 10, 2016-- Heron Therapeutics, Inc. (NASDAQ:HRTX), today announced that the U.S. Food and Drug Administration (FDA) has approved Sustol (granisetron) extended-release injection. Sustol is a serotonin-3 (5-HT3) receptor antagonist indicated in combination with other antiemetics in adults for the prevention of acute and delayed nausea and vomiting ...

Insys Therapeutics Announces FDA Approval of Syndros (dronabinol) Oral Solution

Posted 5 Jul 2016 by Drugs.com

PHOENIX, July 05, 2016 (GLOBE NEWSWIRE) – Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ:INSY) today announced that the U.S. Food and Drug Administration (FDA) has approved Insys’ dronabinol oral solution, Syndros, an orally administered liquid formulation of the pharmaceutical cannabinoid dronabinol, a pharmaceutical version of tetrahydrocannabinol ("THC"). Syndros is approved for ...

Cancer's Heavy Financial Burden

Posted 8 Jun 2016 by Drugs.com

WEDNESDAY, June 8, 2016 – Many cancer patients can't afford to see their doctor or take the medications they've been prescribed, a new study finds. And the problem will likely only get worse as the cost of cancer treatments continues to rise, the study authors said. "You can prescribe the best drug in the world, but if patients can't afford it and they can't get it, then it won't be effective," ...

Researchers Find 8 Immune Genes in Aggressive Brain Cancer

Posted 25 May 2016 by Drugs.com

WEDNESDAY, May 25, 2016 – Researchers have identified immune genes that may affect how long people live after diagnosis with a common type of brain cancer. If confirmed in other studies, the researchers say their findings could lead to improved treatment in the future. The type of brain cancer in the study is glioblastoma multiforme, a fast-growing tumor. People with this type of cancer survive ...

Additional Treatments Offer Little Benefit for Pancreatic Cancer: Study

Posted 3 May 2016 by Drugs.com

TUESDAY, May 3, 2016 – Additional treatments for locally advanced pancreatic cancer don't appear to boost survival, a new French study reports. Researchers looked at the effects of adding a second drug – erlotinib (Tarceva) – to the initial round of chemotherapy. They also tested whether adding radiation to a second round of chemotherapy (chemoradiotherapy) would offer any survival benefit. ...

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Nausea / Vomiting

Related Drug Support Groups

gabapentin, Ativan, lorazepam, Zofran, dexamethasone, olanzapine, Reglan, ondansetron, Marinol, view more... Decadron, metoclopramide, cannabis, nabilone, dronabinol, Cesamet, Emend, Zofran ODT, Varubi, Kytril, Sancuso, Dexone, Adrenocot, Adrenocot LA, Cinvanti, Maxolon, Sustol, Syndros, Akynzeo, Decaject LA, Decaject, Dalalone LA, Dalalone DP, Dalalone, Zema Pak, Lorazepam Intensol, Zuplenz, Baycadron, Zonacort, LoCort, Dexamethasone Intensol, ZoDex, Emend for Injection, Granisol, aprepitant, Dexpak Taperpak, Hexadrol, dolasetron, granisetron, palonosetron, fosaprepitant, netupitant / palonosetron, rolapitant, fosnetupitant / palonosetron, Anzemet, Aloxi, Decadron-LA, Medidex LA, Solurex LA, Dexacen-4, Solurex, Dexacort-LA, Dexasone, Dexasone LA, Dexone LA, Primethasone, Dexacorten, Medidex, De-Sone LA